CoChat

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET

Open access
Lanzenberger, R, Baldinger, P, Hahn, A, Ungersboeck, J, Mitterhauser, M, Winkler, D, Micskei, Z, Stein, P, Karanikas, G, Wadsak, W, Kasper, S, Frey, R · 2013 · Molecular Psychiatry
Cited by 120

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Electroconvulsive therapy (ECT) is a potent therapy in severe treatment-refractory depression. Although commonly applied in psychiatric clinical routine since decades, the exact neurobiological mechanism regarding its efficacy remains unclear. Results from preclinical and clinical studies emphasize a crucial involvement of the serotonin-1A receptor (5-HT(1A)) in the mode of action of antidepressant treatment. This includes associations between treatment response and changes in 5-HT(1A) function and density by antidepressants. Further, alterations of the 5-HT(1A) receptor are consistently reported in depression. To elucidate the effect of ECT on 5-HT(1A) receptor binding, 12 subjects with severe treatment-resistant major depression underwent three positron emission tomography (PET) measurements using the highly selective radioligand [carbonyl-(11)C]WAY100635, twice before (test-retest variability) and once after 10.08±2.35 ECT sessions. Ten patients (~83%) were responders to ECT. The voxel-wise comparison of the 5-HT(1A) receptor binding (BP(ND)) before and after ECT revealed a widespread reduction in cortical and subcortical regions (P<0.05 corrected), except for the occipital cortex and the cerebellum. Strongest reductions were found in regions consistently reported to be altered in major depression and involved in emotion regulation, such as the subgenual part of the anterior cingulate cortex (-27.5%), the orbitofrontal cortex (-30.1%), the amygdala (-31.8%), the hippocampus (-30.6%) and the insula (-28.9%). No significant change was found in the raphe nuclei. There was no significant difference in receptor binding in any region comparing the first two PET scans conducted before ECT. This PET study proposes a global involvement of the postsynaptic 5-HT(1A) receptor binding in the effect of ECT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2012.93

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 62

  1. Thase ME . Treatment-resistant depression: prevalence, risk factors, and treatment strategies. J Clin Psychiatry 2011; 72: e18. · DOI · Paper page
  2. Spindelegger C, Lanzenberger R, Wadsak W, Mien LK, Stein P, Mitterhauser M et al. Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders. Mol Psychiatry 2008; 14: 1040–1050. · DOI
  3. Stimpson N, Agrawal N, Lewis G . Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Br J Psychiatry 2002; 181: 284–294. · DOI · Paper page
  4. Husain SS, Kevan IM, Linnell R, Scott AI . Electroconvulsive therapy in depressive illness that has not responded to drug treatment. J Affect Disord 2004; 83: 121–126. · DOI
  5. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007; 8: 67–104. · DOI · Paper page
  6. Schosser A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S et al. European Group for the Study of Resistant Depression (GSRD) - where have we gone so far: review of clinical and genetic findings. Eur Neuropsychopharmacol 2012; 22: 453–468. · DOI
  7. Frey R, Schreinzer D, Heiden A, Kasper S . Use of electroconvulsive therapy in psychiatry]. Nervenarzt 2001; 72: 661–676. · DOI
  8. Abrams R . Stimulus titration and ECT dosing. J ECT 2002; 18: 3–9. · DOI · Paper page
  9. Folkerts HW, Michael N, Tolle R, Schonauer K, Mucke S, Schulze-Monking H . Electroconvulsive therapy vs paroxetine in treatment-resistant depression—a randomized study. Acta Psychiatr Scand 1997; 96: 334–342. · DOI · Paper page
  10. Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ . World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002; 3: 5–43. · DOI · Paper page
  11. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157 (4 Suppl): 1–45.
  12. Semkovska M, McLoughlin DM . Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68: 568–577. · DOI · Paper page
  13. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153: 985–992. · DOI · Paper page
  14. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S . The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990; 10: 96–104. · DOI · Paper page
  15. Lock T, McCulloch J . Local cerebral glucose utilization after chronic electroconvulsive shock: implications for the mode of action of electroconvulsive therapy. J Psychopharmacol 1991; 5: 111–119. · DOI
  16. Ackermann RF, Engel J, Baxter L . Positron emission tomography and autoradiographic studies of glucose utilization following electroconvulsive seizures in humans and ratsa. Annals N Y Acad Sci 1986; 462: 263–269. · DOI
  17. Engel Jr J, Kuhl DE, Phelps ME . Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 1982; 218: 64–66. · DOI · Paper page
  18. Yatham LN, Clark CC, Zis AP . A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression. J ECT 2000; 16: 171–176. · DOI
  19. Volkow ND, Bellar S, Mullani N, Jould L, Dewey S . Effects of electroconvulsive therapy on brain glucose metabolism: a preliminary study. Convuls Ther 1988; 4: 199–205.
  20. Prohovnik I, Sackeim HA, Decina P, Malitz S . Acute reductions of regional cerebral blood flow following electroconvulsive therapy. Interactions with modality and time. Ann N Y Acad Sci 1986; 462: 249–262. · doi:10.1111/j.1749-6632.1986.tb51259.x
  21. Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK et al. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 2007; 61: 1081–1089. · DOI · Paper page
  22. Best J, Nijhout HF, Reed M . Bursts and the efficacy of selective serotonin reuptake inhibitors. Pharmacopsychiatry 2011; 44 (Suppl 1): S76–S83. · DOI · Paper page
  23. Schildkraut JJ . The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122: 509–522. · DOI · Paper page
  24. Heninger GR, Charney DS, Sternberg DE . Serotonergic function in depression: prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry 1984; 41: 398–402. · DOI · Paper page
  25. Jans LA, Riedel WJ, Markus CR, Blokland A . Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 2007; 12: 522–543. · DOI · Paper page
  26. Savitz J, Lucki I, Drevets WC . 5-HT1A receptor function in major depressive disorder. Prog Neurobiol 2009; 88: 17–31. · DOI · Paper page
  27. Hornung JP . The Neuroanatomy of the Serotonergic System. In: Müller CP, Jacobs BL (eds). Handbook of the Behavioral Neurobiology of Serotonin. Academic Press: London, UK, 2010, pp 51–64.
  28. Kranz GS, Kasper S, Lanzenberger R . Reward and the serotonergic system. Neuroscience 2010; 166: 1023–1035. · DOI · Paper page
  29. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G . Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998; 18: 7394–7401. · DOI · Paper page
  30. Chaput Y, de Montigny C, Blier P . Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 1991; 5: 219–229.
  31. Nash JR, Sargent PA, Rabiner EA, Hood SD, Argyropoulos SV, Potokar JP et al. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry 2008; 193: 229–234. · DOI · Paper page
  32. Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 2004; 24: 589–591. · DOI · Paper page
  33. Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008; 11: 465–476. · DOI · Paper page
  34. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang Y-y et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006; 59: 106–113. · DOI · Paper page
  35. Goodwin GM, De Souza RJ, Green AR . Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology (Berl) 1987; 91: 500–505. · doi:10.1007/bf00216018
  36. de Montigny C . Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther 1984; 228: 230–234. · DOI
  37. Burnet PW, Sharp T, LeCorre SM, Harrison PJ . Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock. Neurosci Lett 1999; 277: 79–82. · DOI
  38. Blier P, Bouchard C . Effect of repeated electroconvulsive shocks on serotonergic neurons. Eur J Pharmacol 1992; 211: 365–373. · DOI
  39. Ishihara K, Amano T, Hayakawa H, Yamawaki S, Sasa M . Enhancement of serotonin1A receptor function following repeated electroconvulsive shock in young rat hippocampal neurons in vitro. Int J Neuropsychopharmacol 1999; 2: 101–104. · DOI
  40. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57: 425–434. · DOI · Paper page
  41. Wadsak W, Mien LK, Ettlinger DE, Lanzenberger RR, Haeusler D, Dudczak R et al. Simple and fully automated preparation of [carbonyl-11C]WAY-100635. Radiochim Acta 2007; 95: 417–442. · DOI
  42. Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L . Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging 2009; 36: 1639–1650. · DOI · Paper page
  43. Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek B, Brown GM et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry 1999; 156: 1029–1034. · DOI · Paper page
  44. Fink M, Wadsak W, Savli M, Stein P, Moser U, Hahn A et al. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. Neuroimage 2009; 45: 598–605. · DOI
  45. Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C et al. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging 2008; 35: 2159–2168. · DOI
  46. Hagemann G, Ugur T, Schleussner E, Mentzel HJ, Fitzek C, Witte OW et al. Changes in brain size during the menstrual cycle. PLoS One 2011; 6: e14655. · DOI · Paper page
  47. Hahn A, Lanzenberger R, Wadsak W, Spindelegger C, Moser U, Mien L-K et al. Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders. J Neuroscience 2010; 30: 14482–14489. · DOI · Paper page
  48. Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003; 23: 1096–1112. · DOI · Paper page
  49. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273–289. · DOI · Paper page
  50. Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res 1997; 745: 96–108. · DOI · Paper page
  51. Abrams R . Electroconvulsive therapy (ECT) practice in Metropolitan New York community hospitals. Psychol Med 2002; 32: 1323–1324; author reply 1324–1326. · DOI
  52. Yasuno F, Suhara T, Ichimiya T, Takano A, Ando T, Okubo Y . Decreased 5-HT1A receptor binding in amygdala of schizophrenia. Biol Psychiatry 2004; 55: 439–444. · DOI · Paper page
  53. Lanzenberger R, Wadsak W, Spindelegger C, Mitterhauser M, Akimova E, Mien L-K et al. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. Int J Neuropsychopharmacol 2010; 13: 1129–1143. · DOI · Paper page
  54. Sullivan GM, Ogden RT, Oquendo MA, Kumar JSD, Simpson N, Huang Y-y et al. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol Psychiatry 2009; 66: 223–230. · DOI · Paper page
  55. Klumpers F, Raemaekers MA, Ruigrok AN, Hermans EJ, Kenemans JL, Baas JM . Prefrontal mechanisms of fear reduction after threat offset. Biol Psychiatry 2010; 68: 1031–1038. · DOI
  56. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion—induced depressive relapse. Arch Gen Psychiatry 1997; 54: 364–374. · DOI · Paper page
  57. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J et al. Brain serotonin1a receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000; 57: 174–180. · DOI · Paper page
  58. Akimova E, Lanzenberger R, Kasper S . The serotonin-1A receptor in anxiety disorders. Biol Psychiatry 2009; 66: 627–635. · DOI · Paper page
  59. Moses-Kolko EL, Price JC, Thase ME, Meltzer CC, Kupfer DJ, Mathis CA et al. Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse 2007; 61: 523–530. · DOI · Paper page
  60. Strome EM, Clark CM, Zis AP, Doudet DJ . Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: An in vivo positron emission tomography study with [18F]setoperone. Biol Psychiatry 2005; 57: 1004–1010. · DOI
  61. Yatham LN, Liddle PF, Lam RW, Zis AP, Stoessl AJ, Sossi V et al. Effect of electroconvulsive therapy on brain 5-HT receptors in major depression. Br J Psychiatry 2010; 196: 474–479. · DOI · Paper page
  62. Saijo T, Takano A, Suhara T, Arakawa R, Okumura M, Ichimiya T et al. Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635. Int J Neuropsychopharmacol 2010; 13: 785–791. · DOI

Cited by

See all 120

Metadata

Authors
Lanzenberger, R., Baldinger, P., Hahn, A., Ungersboeck, J., Mitterhauser, M., Winkler, D., Micskei, Z., Stein, P., Karanikas, G., Wadsak, W., Kasper, S., & Frey, R.
Venue
Molecular Psychiatry
Published
2012-07-03
Volume
18
Issue
1
Pages
93-100
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W1979231444
Cited by
120
References
12
FWCI
5.74
Type
journal article
Language
en
Update notices
erratum (2013-01-29)
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. https://app.cochat.ai/papers/10.1038/mp.2012.93
The paper
Lanzenberger, R., Baldinger, P., Hahn, A., Ungersboeck, J., Mitterhauser, M., Winkler, D., Micskei, Z., Stein, P., Karanikas, G., Wadsak, W., Kasper, S., & Frey, R. (2013). Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Molecular Psychiatry. https://doi.org/10.1038/mp.2012.93

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.